Home » Newsletters » BioWorld

BioWorld

May 12, 1993

View Archived Issues

FDA APPROVES RIBI IND

ALEX. BROWN CONFERENCE: XOMA FOCUSES ON BPI

ALEX. BROWN CONFERENCE: SCHERING TO MARKET ETHYOL IN EUROPE

ALEX. BROWN CONFERENCE: VESTAR PLANS TRIAL ON TB DRUG

QUIDEL TO COLLABORATE WITH EPITOPE

ALEX. BROWN CONFERENCE: SHAMAN TO TEST HERPES DRUG

CANTAB SIGNS PACT WITH OXFORD

GI, AMGEN RESOLVE EPO PATENT DISPUTE

NEORX BEGINS TRIAL FOR MANUFACTURER

BIOSYS BUYS PHEROMONE COMPANY

ALEX. BROWN CONFERENCE: 'HILLARY WOULD LOVE THIS'

ALEX. BROWN CONFERENCE: AMYLIN VS. DIABETES

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...